Alkermes, Inc.: Alcoholism trials
The registry lists 11 Alcoholism studies with Alkermes, Inc. as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 2Phase 2 2Phase 3 6Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderCompletedNCT02161718Phase 2Results posted
- ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218997Phase 3Results posted
- ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218971Phase 3Results posted
- ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent AdultsCompletedNCT01218958Phase 3Results posted
- ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent AdultsCompletedNCT00511836Phase 4Results posted
- ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced AbstinenceCompletedNCT00501631Phase 3Results posted
- ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])TerminatedNCT00156936Phase 3Results posted
- ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent AdultsCompletedNCT00156923Phase 3Results posted
- ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol DependenceCompletedNCT00981617Phase 2
- ALK29-002: A Study of Baclofen Formulations in Healthy AdultsCompletedNCT00802035Phase 1
- ALK33-001: A Study of RDC-0313 Administered to Healthy AdultsCompletedNCT00800319Phase 1